(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLINIPORT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLINIPORT

ST13

US500000079155204

Class

35, 42, 44

Filing

79155204

Registration

4741421

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

03/24/2026

Trademark type

Word

Nice classes

35, 42, 44

Filing date

08/12/2014

Registration date

05/26/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/05/2026

Last transaction

03/24/2026

Responsible office

United States Patent and Trademark Office

Status code

707

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Burton On Trent, GB

Examiner

CHANG, ELIZABETH YI HSUAN

Current location

Historical data usage

Holders and representatives

Holders

Clinigen Healthcare Limited

Representatives

Cynthia A. Moyer Fredrikson & Byron, P.A.

Technical classification

Nice Classes

Class 35Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business management services; business administration services; provision of business statistical information relating to medical matters; collection and systemisation of business data; retail and Wholesale store services featuring pharmaceutical preparations and medical supplies ; compilation of information into computer databases; compilation of statistics; computerised file management services; maintaining personal medical history records and files

Class 42

Providing medical and scientific research information in the field of pharmaceuticals products; pharmaceutical product evaluation services; pharmaceutical research and development services; information technology consulting services for the pharmaceutical and healthcare industries; provision of medical and scientific research information in the field of pharmaceutical products

Class 44

Medical services; pharmaceutical consultancy; Health care servicescollection of information relating to the use of pharmaceuticals and medical treatment; advisoryconsultancy and information services relating to medical servicesmedical treatment services and pharmaceutical compounding services; medical advisoryconsultancy and information services; medical evaluation services; issuing of medical reports; medical information retrieval servicesproviding medical information; medical reporting servicescompilation of medical reports; provision of medical information; advisoryconsultancy and information services relating to medical services for treatment of conditions of the human body; services for the provision of medical care information

Publications

History of USPTO decisions and trademark events.

52 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

03/05/2026

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

03/05/2026

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

02/27/2026

PR71

POST REGISTRATION ACTION MAILED - SEC.71

08/28/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/25/2025

ES71

TEAS SECTION 71 RECEIVED

05/27/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

08/09/2024

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

05/26/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/21/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/21/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/21/2023

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

09/11/2022

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

08/04/2022

INPC

INVALIDATION PROCESSED

08/04/2022

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

05/10/2022

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

09/10/2021

NA15

SEC. 15 ACKNOWLEDGEMENT - E-MAILED

09/10/2021

15AK

REGISTERED - SEC. 15 ACKNOWLEDGED

09/10/2021

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

09/10/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/07/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/03/2021

E15R

TEAS SECTION 15 RECEIVED

06/23/2021

ES71

TEAS SECTION 71 RECEIVED

05/26/2021

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/26/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/12/2017

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/09/2015

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/22/2015

FIMP

FINAL DISPOSITION PROCESSED

09/21/2015

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/26/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

05/26/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/10/2015

PUBO

PUBLISHED FOR OPPOSITION

03/10/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/18/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/02/2015

ALIE

ASSIGNED TO LIE

01/29/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/09/2015

XAEC

EXAMINER'S AMENDMENT ENTERED

01/09/2015

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/09/2015

GNEA

EXAMINERS AMENDMENT E-MAILED

01/09/2015

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/09/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/08/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/08/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/08/2015

RFNP

REFUSAL PROCESSED BY IB

12/20/2014

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/02/2014

RFRR

REFUSAL PROCESSED BY MPU

12/02/2014

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/29/2014

CNRT

NON-FINAL ACTION WRITTEN

11/28/2014

DOCK

ASSIGNED TO EXAMINER

11/28/2014

MAFR

APPLICATION FILING RECEIPT MAILED

11/25/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/21/2014

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/20/2014

Continuous trademark protection

Get notified about every new filing that threatens CLINIPORT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.